Dermatologic and Ophthalmic Drugs Advisory Committee

Results: 196



#Item
181[removed]Federal Register / Vol. 67, No[removed]Tuesday, June 25, [removed]Notices Federal Programs’’ Executive Order[removed]and 45 CFR part 100 for a

[removed]Federal Register / Vol. 67, No[removed]Tuesday, June 25, [removed]Notices Federal Programs’’ Executive Order[removed]and 45 CFR part 100 for a

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2002-06-25 06:27:36
182[removed]Federal Register / Vol. 68, No[removed]Monday, August 18, [removed]Notices Therefore, under section 505(e) of the Federal Food, Drug, and Cosmetic Act

[removed]Federal Register / Vol. 68, No[removed]Monday, August 18, [removed]Notices Therefore, under section 505(e) of the Federal Food, Drug, and Cosmetic Act

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2003-08-18 06:53:28
183

PDF Document

Add to Reading List

Source URL: www.fda.gov

Language: English
184

PDF Document

Add to Reading List

Source URL: www.fda.gov

Language: English
185Health / Dermatologic and Ophthalmic Drugs Advisory Committee / Center for Devices and Radiological Health / Medical device / Center for Veterinary Medicine / Food and Drug Administration / Medicine / Pharmaceutical sciences

DOC Document

Add to Reading List

Source URL: www.fda.gov

Language: English
186

PDF Document

Add to Reading List

Source URL: www.fda.gov

Language: English
187

PDF Document

Add to Reading List

Source URL: www.fda.gov

Language: English
188

PDF Document

Add to Reading List

Source URL: www.fda.gov

Language: English
189

PDF Document

Add to Reading List

Source URL: www.fda.gov

Language: English
190

PDF Document

Add to Reading List

Source URL: www.fda.gov

Language: English